[Lipoprotein-mediated functional changes in the fibrinolytic system in the genesis of atherosclerosis].
García Frade
L J
LJ
Servicio de Hematología, Hospital Ramón y Cajal, Madrid.
García Avello
A
A
D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology*; D004730:Endothelium, Vascular / Q000378:metabolism; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000172:deficiency / Q000502:physiology*; D015849:Plasminogen Inactivators / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000502:physiology; D055293:Receptors, Urokinase Plasminogen Activator; D013927:Thrombosis / Q000097:blood / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000502:physiology
D017270:Lipoprotein(a); D008074:Lipoproteins; C524898:PLAUR protein, human; D015849:Plasminogen Inactivators; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D005337:Fibrin; D010959:Tissue Plasminogen Activator
Alteración funcional del sistema fibrinolítico mediada por lipoproteínas en la génesis de aterosclerosis.